PAC Questions UGX 723 Billion Dei BioPharma Investment Amid Cancer Drug Plans
Uganda’s Public Accounts Committee (PAC) has questioned the government’s decision to inject more than UGX 723 billion into Dei BioPharma Ltd without first conducting a valuation, only to later discover the company was worth just UGX 2.05 billion. The concern was raised by Butambala County MP Muwanga Kivumbi on September 9 while presenting PAC’s report…
